share_log

RBC Capital Reiterates Outperform on IDEAYA Biosciences, Maintains $36 Price Target

Benzinga ·  Dec 6, 2023 10:52

RBC Capital analyst Gregory Renza reiterates IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and maintains $36 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment